We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.17B
AUM Growth
+$69.9M
Cap. Flow
-$123M
Cap. Flow %
-10.45%
Top 10 Hldgs %
45.17%
Holding
233
New
50
Increased
46
Reduced
102
Closed
21

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Technology 3.54%
3 Communication Services 2.54%
4 Healthcare 2.13%
5 Industrials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
26
iShares MSCI EAFE ETF
EFA
$76.5B
$11M 0.94%
468,167
-46,499
-9% -$2.81M
SCHP icon
27
Schwab US TIPS ETF
SCHP
$16.5B
$10.5M 0.9%
+379,440
New +$10.5M
EEM icon
28
iShares MSCI Emerging Markets ETF
EEM
$28B
$10M 0.85%
382,598
-22,894
-6% -$870K
CINF icon
29
Cincinnati Financial
CINF
$28B
$9.67M 0.82%
133,750
-15,690
-10% -$1.14M
META icon
30
Meta Platforms (Facebook)
META
$1.64T
$9.47M 0.81%
66,673
+53,913
+423% +$7.2M
IWM icon
31
iShares Russell 2000 ETF
IWM
$82.2B
$9.27M 0.79%
134,896
+37,942
+39% +$5.18M
VWO icon
32
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$7.71M 0.66%
194,112
+34,513
+22% +$1.33M
IWD icon
33
iShares Russell 1000 Value ETF
IWD
$81.9B
$7.44M 0.63%
64,710
-3,762
-5% -$431K
JNJ icon
34
Johnson & Johnson
JNJ
$609B
$6.69M 0.57%
53,693
+8,097
+18% +$967K
VCIT icon
35
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.7B
$5.7M 0.49%
+65,976
New +$5.67M
DATA
36
DELISTED
Tableau Software, Inc.
DATA
$5.61M 0.48%
+113,247
New +$5.6M
HDV
37
iShares Core High Dividend ETF
HDV
$14.2B
$5.52M 0.47%
1,140,100
+48,085
+4% +$802K
IEFA icon
38
iShares Core MSCI EAFE ETF
IEFA
$186B
$5.52M 0.47%
95,218
+70,671
+288% +$3.97M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.23T
$5.46M 0.47%
128,840
+118,000
+1,089% +$4.96M
JPM icon
40
JPMorgan Chase
JPM
$907B
$5.3M 0.45%
60,320
-8,427
-12% -$743K
MUB icon
41
iShares National Muni Bond ETF
MUB
$45.5B
$5.28M 0.45%
48,439
-997,267
-95% -$108M
SCHZ icon
42
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$4.92M 0.42%
+190,142
New +$4.91M
PG icon
43
Procter & Gamble
PG
$349B
$4.65M 0.4%
51,742
-21,204
-29% -$1.88M
IFGL icon
44
iShares International Developed Real Estate ETF
IFGL
$82M
$4.43M 0.38%
161,227
-519
-0.3% -$14.1K
PEP icon
45
PepsiCo
PEP
$187B
$4.4M 0.37%
39,365
-1,078
-3% -$116K
IWR icon
46
iShares Russell Mid-Cap ETF
IWR
$56.6B
$4.35M 0.37%
93,052
-2,232
-2% -$103K
DIS icon
47
Walt Disney
DIS
$170B
$3.97M 0.34%
34,998
-172
-0.5% -$18.9K
USB icon
48
US Bancorp
USB
$98.4B
$3.96M 0.34%
76,979
-4,118
-5% -$220K
O icon
49
Realty Income
O
$61.3B
$3.94M 0.34%
68,266
-24,412
-26% -$1.41M
IWV icon
50
iShares Russell 3000 ETF
IWV
$19.6B
$3.9M 0.33%
27,842
-3,997
-13% -$552K

Similar funds

Aspiriant LLC's Q1 2017 Portfolio in Review

As of Q1 2017, Aspiriant LLC held 233 positions worth $1.17B, up 6.3% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Aspiriant LLC withdrew a net $123M in Q1 2017, closing 21 positions and reducing 102 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $2.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 5.1% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Vanguard Short-Term Corporate Bond ETF worth $19.1M.

  • Aspiriant LLC's largest Q1 2017 buy was Vanguard Short-Term Corporate Bond ETF: 240,133 shares worth $19.1M.
  • Aspiriant LLC added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $30.7M increase.
  • Aspiriant LLC's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $124M.
  • Aspiriant LLC fully exited VanEck Biotech ETF in Q1 2017, selling an estimated $2.5M.
  • Aspiriant LLC's ten largest holdings make up 45% of its $1.17B portfolio in Q1 2017.
  • Aspiriant LLC opened 50 new positions and closed 21 in Q1 2017.
  • Aspiriant LLC's portfolio value rose 6.3% quarter-over-quarter to $1.17B.

Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.